These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28549500)

  • 61. Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia.
    Sun D; Zhou BY; Zhao X; Li S; Zhu CG; Guo YL; Gao Y; Wu NQ; Liu G; Dong Q; Li JJ
    J Clin Lab Anal; 2018 Sep; 32(7):e22442. PubMed ID: 29603377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
    Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).
    Paramsothy P; Knopp RH; Bertoni AG; Blumenthal RS; Wasserman BA; Tsai MY; Rue T; Wong ND; Heckbert SR
    J Am Coll Cardiol; 2010 Sep; 56(13):1034-41. PubMed ID: 20846602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Miname MH; Santos RD
    Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
    Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
    Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Leysen X; Van Leuven F; Heller FR
    Eur J Clin Invest; 2001 Nov; 31(11):958-65. PubMed ID: 11737238
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
    Mangili LC; Mangili OC; Bittencourt MS; Miname MH; Harada PH; Lima LM; Rochitte CE; Santos RD
    Atherosclerosis; 2016 Nov; 254():73-77. PubMed ID: 27705756
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.
    Plana N; Rodríguez-Borjabad C; Ibarretxe D; Ferré R; Feliu A; Caselles A; Masana L;
    Clin Investig Arterioscler; 2018; 30(4):170-178. PubMed ID: 29602595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort.
    Lima IR; Tada MT; Oliveira TGM; Jannes CE; Bensenor I; Lotufo PA; Santos RD; Krieger JE; Pereira AC
    Atheroscler Plus; 2022 Aug; 49():47-55. PubMed ID: 36644206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
    Eyrich TM; Dalila N; Christoffersen M; Tybjærg-Hansen A; Stender S
    Atherosclerosis; 2024 Oct; 397():118574. PubMed ID: 39244851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis.
    Natarajan P; Bis JC; Bielak LF; Cox AJ; Dörr M; Feitosa MF; Franceschini N; Guo X; Hwang SJ; Isaacs A; Jhun MA; Kavousi M; Li-Gao R; Lyytikäinen LP; Marioni RE; Schminke U; Stitziel NO; Tada H; van Setten J; Smith AV; Vojinovic D; Yanek LR; Yao J; Yerges-Armstrong LM; Amin N; Baber U; Borecki IB; Carr JJ; Chen YI; Cupples LA; de Jong PA; de Koning H; de Vos BD; Demirkan A; Fuster V; Franco OH; Goodarzi MO; Harris TB; Heckbert SR; Heiss G; Hoffmann U; Hofman A; Išgum I; Jukema JW; Kähönen M; Kardia SL; Kral BG; Launer LJ; Massaro J; Mehran R; Mitchell BD; Mosley TH; de Mutsert R; Newman AB; Nguyen KD; North KE; O'Connell JR; Oudkerk M; Pankow JS; Peloso GM; Post W; Province MA; Raffield LM; Raitakari OT; Reilly DF; Rivadeneira F; Rosendaal F; Sartori S; Taylor KD; Teumer A; Trompet S; Turner ST; Uitterlinden AG; Vaidya D; van der Lugt A; Völker U; Wardlaw JM; Wassel CL; Weiss S; Wojczynski MK; Becker DM; Becker LC; Boerwinkle E; Bowden DW; Deary IJ; Dehghan A; Felix SB; Gudnason V; Lehtimäki T; Mathias R; Mook-Kanamori DO; Psaty BM; Rader DJ; Rotter JI; Wilson JG; van Duijn CM; Völzke H; Kathiresan S; Peyser PA; O'Donnell CJ;
    Circ Cardiovasc Genet; 2016 Dec; 9(6):511-520. PubMed ID: 27872105
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients.
    Wang L; Lin J; Liu S; Cao S; Liu J; Yong Q; Yang Y; Wu B; Pan X; Du L; Wu C; Qin Y; Chen B
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):391-400. PubMed ID: 19073363
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between carotid disease on ultrasound and coronary disease on CT angiography.
    Cohen GI; Aboufakher R; Bess R; Frank J; Othman M; Doan D; Mesiha N; Rosman HS; Szpunar S
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1160-7. PubMed ID: 24229768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects.
    Tonstad S; Joakimsen O; Stensland-Bugge E; Ose L; Bønaa KH; Leren TP
    Eur J Clin Invest; 1998 Dec; 28(12):971-9. PubMed ID: 9893006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
    Talmud PJ; Shah S; Whittall R; Futema M; Howard P; Cooper JA; Harrison SC; Li K; Drenos F; Karpe F; Neil HA; Descamps OS; Langenberg C; Lench N; Kivimaki M; Whittaker J; Hingorani AD; Kumari M; Humphries SE
    Lancet; 2013 Apr; 381(9874):1293-301. PubMed ID: 23433573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.